Oncorus, Inc.
ONCR
ONCR was delisted on the 20th of June, 2023.
47 hedge funds and large institutions have $552M invested in Oncorus, Inc. in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$66M |
| 2 |
DM
Deerfield Management
New York
|
+$66M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$55M |
| 4 |
PA
Perceptive Advisors
New York
|
+$46.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$43.5M |
Top Sellers
ONCR Hedge Fund Activity: Q4 2020 in Review
47 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Oncorus, Inc. (ONCR) for Q4 2020, worth a combined $552M.
Buyers outnumbered sellers: 47 funds opened new ONCR positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was MPM Asset Management, opening a new position worth an estimated $66M.
- 47 institutional investors held Oncorus, Inc. (ONCR) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $552M of Oncorus, Inc. stock for Q4 2020.
- 47 funds opened new Oncorus, Inc. positions in Q4 2020 and 0 closed out, a net change of +47 holders.
- The largest Oncorus, Inc. buyer in Q4 2020 was MPM Asset Management, an estimated $66M added.
Based on aggregated 13F filings for Q4 2020.